Country: Portugal
Language: English
Source: HMA (Heads of Medicines Agencies)
cloprostenol sodium salt 0.08 mg
Calier Portugal, S.A.
QG02AD90
Solution for injection
cloprostenol
Cattle, Horses, Pigs
2007-10-24
LABORATORIOS CALIER VETEGLAN 0.075 mg/ml, Solution for injection Part 1B – SmPC, Label and Package Insert PACKAGE LEAFLET The proposed wording for the package leaflet to be included with this medicinal product is included on the following pages. LABORATORIOS CALIER VETEGLAN 0.075 mg/ml, Solution for injection Part 1B – SmPC, Label and Package Insert PACKAGE LEAFLET VETEGLAN 0.075 MG/ML SOLUTION FOR INJECTION D- CLOPROSTENOL (SODIUM SALT) FOR COWS, SOWS AND MARES 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder and manufacturer: CALIER PORTUGAL, S.A. Centro Empresarial Sintra-Estoril II, Edif. C SINTRA PORTUGAL Manufacturer: LABORATORIOS CALIER, S.A. C/ Barcelonès, 26 (Pla de Ramassà) LES FRANQUESES DEL VALLÈS, (Barcelona) SPAIN KERN PHARMA S.L. Pol. Ind. Colon II, c/Venus 72 08228 Terrasa Barcelona SPAIN 2. NAME OF THE VETERINARY MEDICINAL PRODUCT VETEGLAN 0.075 mg/ml Solution for injection for cows, sows and mares 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) EACH ML CONTAINS: ACTIVE SUBTANCE d- Cloprostenol ...................................................................................... 0.075 mg equivalent to d-Cloprostenol sodium salt……………...…………….… 0.079 mg EXCIPIENT: Chlorocresol ........................................................................................... 1.000 mg Excipients q.f……………………………………………..…………… 1.000 ml LABORATORIOS CALIER VETEGLAN 0.075 mg/ml, Solution for injection Part 1B – SmPC, Label and Package Insert 4. INDICATION(S) COWS Induction and synchronisation of Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT VETEGLAN 0.075 mg/ml Solution for injection for cows, sows and mares 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains : Active substance d- Cloprostenol ………………...0.075 mg equivalent to d- Cloprostenol sodium salt .…0.079 mg Excipient Chlorocresol........................................... 1.000 mg Excipients q.s.............................................1.000 ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Clear aqueous solution 4. CLINICAL PARTICULARS 4.1.TARGET SPECIES Bovines (cows), porcines (sows) and equines (mares). 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES COWS Induction and synchronisation of oestrus Induction of parturition Ovarian dysfunction due to persistent _corpus luteum_: postpartum anoestrus, silent heat, irregular and anovulatory cycles, persistent _corpus luteum_, luteal cysts; Pyometra, endometritis; Interruption of pregnancy (first stage of gestation) including foetal mummification; Post-puerperium uterine dysfunctions, delayed uterine involution; Therapy associated to the treatment of follicular cysts (10-14 days after administration of GnRH or hCG) SOWS Induction of parturition MARES Induction of parturition Induction of oestrus 4.3. CONTRA-INDICATIONS: Do not use in pregnant animals unless it is desirable to induce parturition or interruption of pregnancy and to animals with spastic dysfunctions of the gastrointestinal tract and/or respiratory system. Do not use in case of hipersensibility Read the complete document